{"SPADE_UN_10207": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 7575750 B2", "Patent Link": "http://www.lens.org/lens/patent/US_7575750_B2", "Patent Type": "Granted Patent", "Publication Date": "2009-8-18", "Family Info": "CA2500248A1,CA2500248C,CN1327897C,CN1668330A,EP1542718A2,EP1542718A4,WO2004029201A2,WO2004029201A3", "Patent Title": "Human immunodeficiency virus (HIV) gp41 peptide derivatives with enhanced solubility and antiviral activity.", "Abstract": "This invention relates to gp41 peptide derivatives that are inhibitors of viral infection and/or exhibit antifusogenic properties. In particular, this invention relates to gp41 derivatives having inhibiting activity against human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) with enhanced duration of action for the treatment of the respective viral infections."}], "Sequence Information": {"SPADE ID": "SPADE_UN_10207", "Sequence": "WMEWDREINNYTSLIHSLIEESQNQQEKNEQELL", "Sequence Length": 34, "Peptide Name": "Sequence 5 from Patent US 7575750", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antiviral"], "Frequent Amino Acids": "ELN", "Absent Amino Acids": "ACFGOPUV", "Basic Residues": 3, "Acidic Residues": 8, "Hydrophobic Residues": 11, "Polar Residues": 16, "Positive Residues": 3, "Negative Residues": 8, "Mass": 4248.55, "PI": 4.21, "Net Charge": -5, "Hydrophobicity": -1.27, "Similar Sequences": [{"SPADE_ID": "SPADE_N_10037", "Similarity": 1.0, "Sequence": "WMEWDREINNYTSLIHSLIEESQNQQEKN"}, {"SPADE_ID": "SPADE_UN_09642", "Similarity": 1.0, "Sequence": "WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLEL"}, {"SPADE_ID": "SPADE_UN_09768", "Similarity": 1.0, "Sequence": "WNASWSNKSLEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF"}]}}}